Asymmetrical Ocular Manifestations of Nephropathic Cystinosis; A Case Report
暂无分享,去创建一个
[1] Achini K. Makuloluwa,et al. Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review , 2018, Clinical ophthalmology.
[2] C. Baudouin,et al. A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study. , 2017, Investigative ophthalmology & visual science.
[3] L. P. Van den Heuvel,et al. Cystinosis: a review , 2016, Orphanet Journal of Rare Diseases.
[4] K. Ramaesh,et al. Treatment of corneal cystine crystal accumulation in patients with cystinosis , 2014, Clinical ophthalmology.
[5] D. Trauner,et al. Nephropathic cystinosis: an international consensus document. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[6] G. Deschênes,et al. A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study. , 2014, Molecular genetics and metabolism.
[7] C. Antignac,et al. Clinical utility gene card for: Cystinosis , 2013, European Journal of Human Genetics.
[8] C. Antignac,et al. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults. , 2012, Kidney international.
[9] C. Bassim,et al. Craniofacial and dental findings in cystinosis. , 2010, Oral diseases.
[10] P. Niaudet,et al. In vivo confocal microscopy and anterior segment optical coherence tomography analysis of the cornea in nephropathic cystinosis. , 2009, Ophthalmology.
[11] W. Gahl,et al. Nephropathic Cystinosis in Adults: Natural History and Effects of Oral Cysteamine Therapy , 2007, Annals of Internal Medicine.
[12] D. Trauner,et al. Non‐verbal deficits in young children with a genetic metabolic disorder: WPPSI‐III performance in cystinosis , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[13] W. Gahl,et al. Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature. , 2007, Survey of ophthalmology.
[14] M. Kaiser-Kupfer,et al. Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy. , 2006, Ophthalmology.
[15] C. Antignac,et al. Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin. , 2004, Human molecular genetics.
[16] M. Kaiser-Kupfer,et al. Age-Related Prevalence of Anterior Segment Complications in Patients With Infantile Nephropathic Cystinosis , 2002, Cornea.
[17] E. Kuehl,et al. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. , 2000, Molecular genetics and metabolism.
[18] O. Gribouval,et al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis , 1998, Nature Genetics.
[19] W. Gahl,et al. Pituitary-Testicular Function in Nephropathic Cystinosis , 1993, Annals of Internal Medicine.
[20] E. Kuehl,et al. A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis. , 1990, Archives of ophthalmology.
[21] M. Kaiser-Kupfer,et al. Long-term ocular manifestations in nephropathic cystinosis. , 1986, Archives of ophthalmology.